The mechanisms of action of metformin.
Level 5 - mechanism / opinion, no new human data
Narrative review of pharmacological and molecular mechanisms
PubMed 28776086 · doi:10.1007/s00125-017-4342-z
What was done
This paper is a narrative review examining the physiological and molecular mechanisms of action underlying metformin's metabolic effects, contrasting acute versus chronic administration and evaluating organ-level and cellular targets.
What was found
The abstract provides no numerical data or quantitative outcomes. It describes that metformin reduces hepatic glucose production and has significant effects in the gut. At the molecular level, its actions involve both AMPK-dependent and AMPK-independent pathways, inhibition of mitochondrial respiration, potential inhibition of mitochondrial glycerophosphate dehydrogenase, and lysosomal mechanisms, with effects varying by dose and duration of treatment.
Why it matters
It highlights that metformin's therapeutic actions extend far beyond simple hepatic AMPK activation to include complex multi-organ and multi-pathway mechanisms.
Limits
The abstract describes a narrative overview rather than a systematic review or meta-analysis. No sample sizes, patient characteristics, search methodologies, or quantitative effect estimates are reported.
Cited by
- context Metformin improves insulin sensitivity to clear glucose from the bloodstream into cells for energy.